Elissavet Kardami Selected Research

Drug Therapy (Chemotherapy)

1/2020	Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes.
4/2019	Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elissavet Kardami Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 05/2007
6	Cardiomegaly (Heart Hypertrophy) 10/2011 - 01/2003
6	Ischemia 10/2009 - 02/2002
5	Cardiotoxicity 04/2019 - 07/2017
5	Hypertrophy 01/2014 - 01/2003
4	Heart Failure 04/2019 - 08/2004
4	Fibrosis (Cirrhosis) 01/2014 - 01/2003
4	Reperfusion Injury 09/2013 - 03/2002
3	Inflammation (Inflammations) 04/2019 - 10/2013
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2018
2	Myocardial Infarction 01/2014 - 03/2002
2	Vascular Remodeling 10/2013 - 01/2003
2	Infections 09/2008 - 04/2003
2	Infarction (Infarctions) 01/2007 - 04/2004
1	Atherosclerosis 04/2019
1	Thrombosis (Thrombus) 04/2019
1	Depressive Disorder (Melancholia) 01/2018
1	Mental Disorders (Mental Disorder) 01/2018
1	ST Elevation Myocardial Infarction 12/2017
1	Hypertension (High Blood Pressure) 10/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013
1	Cardiomyopathies (Cardiomyopathy) 01/2013
1	Essential Hypertension 10/2011
1	Left Ventricular Dysfunction 08/2010
1	Ventricular Remodeling 09/2008
1	Hypoxia (Hypoxemia) 03/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2004
1	Carcinogenesis 01/2003
1	Coronary Occlusion 03/2002

Drug/Important Bio-Agent (IBA)

15	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019 - 02/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019 - 04/2013
4	Pharmaceutical PreparationsIBA 04/2019 - 04/2013
3	Protein Isoforms (Isoforms)IBA 01/2011 - 08/2004
3	ConnexinsIBA 09/2008 - 01/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 12/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 12/2018
2	ResveratrolIBA 10/2013 - 10/2011
2	Connexin 43 (Connexin43)IBA 09/2008 - 01/2003
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2019
1	Heme Oxygenase-1IBA 12/2018
1	AntioxidantsIBA 10/2017
1	Conditioned Culture MediaIBA 01/2014
1	Biological ProductsIBA 01/2014
1	ProcollagenIBA 01/2014
1	Neutralizing AntibodiesIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Hydralazine (Apresoline)FDA LinkGeneric 10/2013
1	AnthracyclinesIBA 04/2013
1	CalreticulinIBA 01/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011
1	Phosphotransferases (Kinase)IBA 10/2011
1	Adenosine Monophosphate (AMP)IBA 10/2011
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2011
1	PolyphenolsIBA 10/2011
1	CholesterolIBA 08/2010
1	LipidsIBA 08/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2010
1	Cytochromes c (Cytochrome c)IBA 10/2009
1	Glucose (Dextrose)FDA LinkGeneric 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2004
1	AngiotensinsIBA 08/2004
1	Troponin T (Troponin T1)IBA 04/2004
1	Histones (Histone)IBA 04/2003
1	fostriecinIBA 01/2003
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2003
1	Okadaic AcidIBA 01/2003
1	calyculin AIBA 01/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2002
1	Protein Kinase CIBA 03/2002
1	chelerythrineIBA 03/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2020 - 04/2019
2	Therapeutics 12/2018 - 12/2017
1	Percutaneous Coronary Intervention 12/2017
1	Ligation 04/2004